NASDAQ:ROIV

Roivant Sciences Stock Earnings Reports

etoro logo Buy ROIV
*Your capital is at risk
$31.25
-0.180 (-0.573%)
At Close: Jun 22, 2026

Roivant Sciences Earnings Calls

Mar 31, 2026
-$0.279 (3.49%)
Release date May 20, 2026
EPS estimate -$0.289
EPS actual -$0.279
EPS Surprise 3.49%
Revenue estimate 3.414M
Revenue actual 2.52M
Revenue Surprise -26.20%
Dec 31, 2025
-$0.240 (19.88%)
Release date Feb 06, 2026
EPS estimate -$0.300
EPS actual -$0.240
EPS Surprise 19.88%
Revenue estimate 5.08M
Revenue actual 1.999M
Revenue Surprise -60.65%
Sep 30, 2025
-$0.202 (36.86%)
Release date Nov 10, 2025
EPS estimate -$0.320
EPS actual -$0.202
EPS Surprise 36.86%
Revenue estimate 5.619M
Revenue actual 1.571M
Revenue Surprise -72.04%
Jun 30, 2025 (Upcoming)
Release date Aug 10, 2026
EPS estimate -$0.330
EPS actual -
Revenue estimate 2.324M
Revenue actual -
Expected change +/- 8.22%

Last 4 Quarters for Roivant Sciences

Below you can see how ROIV performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jun 30, 2025 (Upcoming)
Release date Aug 10, 2026
Price on release -
EPS estimate -$0.330
EPS actual -
Date Price
Jun 15, 2026 $30.03
Jun 16, 2026 $30.41
Jun 17, 2026 $31.20
Jun 18, 2026 $31.43
Jun 22, 2026 $31.25
Sep 30, 2025 Beat
Release date Nov 10, 2025
Price on release $21.17
EPS estimate -$0.320
EPS actual -$0.202
EPS surprise 36.86%
Date Price
Nov 04, 2025 $19.87
Nov 05, 2025 $20.23
Nov 06, 2025 $20.57
Nov 07, 2025 $20.62
Nov 10, 2025 $21.17
Nov 11, 2025 $20.90
Nov 12, 2025 $21.32
Nov 13, 2025 $20.56
Nov 14, 2025 $20.29
4 days before 6.54%
4 days after -4.16%
On release day -1.28%
Change in period 2.11%
Dec 31, 2025 Beat
Release date Feb 06, 2026
Price on release $25.82
EPS estimate -$0.300
EPS actual -$0.240
EPS surprise 19.88%
Date Price
Feb 02, 2026 $21.94
Feb 03, 2026 $21.97
Feb 04, 2026 $21.65
Feb 05, 2026 $21.14
Feb 06, 2026 $25.82
Feb 09, 2026 $27.67
Feb 10, 2026 $27.35
Feb 11, 2026 $26.80
Feb 12, 2026 $26.75
4 days before 17.68%
4 days after 3.60%
On release day 7.16%
Change in period 21.92%
Mar 31, 2026 Beat
Release date May 20, 2026
Price on release $32.41
EPS estimate -$0.289
EPS actual -$0.279
EPS surprise 3.49%
Date Price
May 14, 2026 $29.50
May 15, 2026 $29.29
May 18, 2026 $28.55
May 19, 2026 $28.21
May 20, 2026 $32.41
May 21, 2026 $30.88
May 22, 2026 $29.96
May 26, 2026 $29.67
May 27, 2026 $29.58
4 days before 9.86%
4 days after -8.73%
On release day -4.72%
Change in period 0.271%

Roivant Sciences Earnings History

Earnings Calendar

FAQ

When is the earnings report for ROIV?
Roivant Sciences Ltd. (ROIV) has scheduled its earnings report for Jul 01, 2026 before the markets open.

What is the ROIV price-to-earnings (P/E) ratio?
ROIV P/E ratio as of Jun 22, 2026 (TTM) is -73.62.

What is the ROIV EPS forecast?
The forecasted EPS (Earnings Per Share) for Roivant Sciences Ltd. (ROIV) for the first fiscal quarter 2026 is -$0.308.

What are Roivant Sciences Ltd.'s retained earnings?
On its balance sheet, Roivant Sciences Ltd. reported retained earnings of $2.52 million for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT ROIVANT SCIENCES LTD.
Roivant Sciences
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aur...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE